Feature | Radiation Dose Management
The results of a research study indicate that interventional cardiologists receive “very high” radiation exposure levels to the left side of the head specifically when performing fluoroscopically guided invasive cardiovascular (CV) procedures. Even with modern imaging equipment and shielding, a significant exposure difference was seen between the two sides of the head.
October 06, 2015
Acutus Medical, a global heart rhythm technology company, presented data that show the AcQMap High Resolution Imaging and Mapping System more rapidly and clearly maps atrial fibrillation (AF) than segmented computed tomography (sCT) mapping, the current standard for most AF ablation procedures. The initial study findings were presented during an oral presentation at the 10th annual Heart Rhythm Congress held in Birmingham, United Kingdom, Oct. 4-7, 2015.
October 06, 2015
The novel Aortix device has earned a spot among the diagnostic and therapeutic modalities accepted for presentation in the Interventional Innovation “Shark Tank” Competition at the Transcatheter Cardiovascular Therapeutics (TCT) annual scientific symposium. The event will be held Tuesday, Oct. 13, in San Francisco, California.
October 06, 2015Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News | Cardiovascular Business
GE Healthcare announced the creation of a new business unit, Sustainable Healthcare Solutions (SHS), that will develop high-value, low-cost technologies and healthcare delivery solutions across multiple care settings. The new organization will invest $300 million as part of a multi-phase effort to develop a more robust affordable healthcare portfolio for customers. The unit will combine GE Healthcare’s operations in India, South Asia, Africa and Southeast Asia.
October 06, 2015
News | FFR Technologies
Beaumont Hospital - Royal Oak is the first in Michigan and one of just a handful in the United States to offer fractional flow reserve by computed tomography, also known as FFR-CT. The technology is a noninvasive, diagnostic tool recently approved by the U.S. Food and Drug Administration (FDA) and developed by HeartFlow Inc.
October 05, 2015
Procyrion Inc. of Houston has been awarded the grand prize of $20,000 in the 2015 "Create the Future" Design Contest for the first catheter-deployed heart pump intended for long-term treatment of chronic heart failure.
October 05, 2015Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Technology
October 5, 2015 — The U.S. Food and Drug Administration (FDA) has approved Boston Scientific’s Synergy Bioabsorbable ...
October 05, 2015News | Heart Failure
Cyberonics Inc. announced results from the extension of the ANTHEM-HF clinical study (ENCORE Study). Results of the study presented by a prominent heart failure (HF) specialist during a major cardiology congress in the United States show that autonomic regulation therapy (ART) in patients with moderate to severe chronic HF and impaired heart function is well-tolerated, safe, improves the heart's ability to pump blood, and reduces the frequency and severity of symptoms associated with chronic HF.
October 02, 2015
News | Stents Bifurcation
October 2, 2015 — Tryton Medical Inc. announced that results of a post hoc analysis of the pivotal Tryton Randomized ...
October 02, 2015Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Technology
AtriCure Inc. launched the cryoFORM cryoablation probe, which offers increased probe flexibility to adapt to a variety of surgical ablation procedures. This offering adds to the cryoICE family of ablation products which are used in the cryosurgical treatment of cardiac arrhythmias.
October 02, 2015
Technology | Antiplatelet and Anticoagulation Therapies
AstraZeneca announced that Brilinta (ticagrelor) 60-mg tablets are now available in U.S. pharmacies. On Sept. 3, 2015, the U.S. Food and Drug Administration (FDA) approved a new 60-mg dosage strength for Brilinta to be used in patients with a history of heart attack beyond the first year.
October 02, 2015
Intact Vascular Inc. announced the U.S. Food and Drug Administration has granted conditional approval for a U.S. and European investigational device exemption (IDE) clinical trial of the Tack Endovascular System.
October 01, 2015Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
News | Stents Peripheral
Kimihiko Kichikawa, M.D., department of radiology at Nara Medical University in Japan, reported two-year results of the Zilver PTX post-market surveillance (PMS) study at the 2015 Cardiovascular and Interventional Radiology Society of Europe (CIRSE) meeting in Lisbon, Portugal. Kichikawa’s presentation focused on initial target data on lesion revascularization (TLR).
October 01, 2015
News | Stents Peripheral
Stentys announced that the company’s drug-eluting stent received CE Mark for treatment of below-the-knee (BTK) arteries. The approval makes it the first self-expanding and drug-eluting stent with regulatory approval in Europe for this indication.
October 01, 2015
Technology | Contrast Media Injectors
Galt Medical has partnered with Health Line International Corp. and launched the Nexus CT Midline Catheter with MST Insertion Kit.
October 01, 2015© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now